14th Annual Conference in Advances & Progress in Drug Design

SMi are proud to present the 14th Annual Advances and Progress in Drug Design Conference, convening in Central London on Monday 16 and Tuesday 17 February 2015.

The drug is most commonly an organic small molecule that activates or inhibits the function of a biomolecule such as a protein, which in turn results in a therapeutic benefit to the patient. Drug design involves the designing of small molecules that are complementary in shape and charge to the biomolecular target with which they interact and therefore will bind to it. Drug design, is the inventive process of finding new medications based on the knowledge of the biological target.

As science and technology is advancing, drug designing has moved from traditional methods to advanced methods like computer aided drug designing and computational techniques. This informative event will focus on the recent developments and growth drivers in drug design.

High profile scientists from pharma companies and biotech organisations will be speaking about structure based drug designing, fragment based drug designing, computer based drug designing, pharmacokinetics, polypharmacology and metabolism in drug designing.